Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Harmony Biosciences Holdings (HRMY) Asset Utilization Ratio (2020 - 2025)

Harmony Biosciences Holdings (HRMY) has disclosed Asset Utilization Ratio for 6 consecutive years, with 0.7 as the latest value for Q4 2025.

  • Quarterly Asset Utilization Ratio fell 5.56% to 0.7 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.7 through Dec 2025, down 5.56% year-over-year, with the annual reading at 0.76 for FY2025, 3.12% down from the prior year.
  • Asset Utilization Ratio hit 0.7 in Q4 2025 for Harmony Biosciences Holdings, down from 0.71 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.77 in Q2 2024 to a low of 0.52 in Q1 2021.
  • Historically, Asset Utilization Ratio has averaged 0.71 across 5 years, with a median of 0.72 in 2021.
  • Biggest five-year swings in Asset Utilization Ratio: soared 73.26% in 2021 and later decreased 10.27% in 2022.
  • Year by year, Asset Utilization Ratio stood at 0.74 in 2021, then decreased by 10.27% to 0.66 in 2022, then rose by 10.19% to 0.73 in 2023, then rose by 1.26% to 0.74 in 2024, then fell by 5.56% to 0.7 in 2025.
  • Business Quant data shows Asset Utilization Ratio for HRMY at 0.7 in Q4 2025, 0.71 in Q3 2025, and 0.71 in Q2 2025.